Patents by Inventor Roberta S. Hare

Roberta S. Hare has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Particulate-stabilized injectable pharmacutical compositions of posaconazole
    Publication number: 20090226527
    Abstract: The present invention provides formulations useful for treating infections, in particular, formulations that include the active pharmaceutical ingredient Posaconazole in an injectable suspension of particles that is stable when subjected to terminal sterilization. Preferred median particle sizes of between 1.5 and 3.0 microns are found to result in superior pharmacokinetic characteristics-displayed in FIG. 7.
    Type: Application
    Filed: March 3, 2009
    Publication date: September 10, 2009
    Inventors: Leonore Witchey-Lakshmanan, Sydney Ugwu, Varda E. Sandweiss, Catherine Hardalo, Roberta S. Hare, Gopal Krishna, Zaiqi Wang, Marco Taglietti
  • Method to identify fungal genes useful as antifungal targets
    Patent number: 6505126
    Abstract: The invention provides methods for identifying nucleic acids and polypeptides derived from fungi that are useful as antifungal targets for diagnosis and/or treatment of fungal diseases. The invention also provides isolated fungal-specific nucleic acids and polypeptides comprising antifungal targets. Methods for identifying antifungal agents that interact with and/or alter the function the antifungal targets are provided.
    Type: Grant
    Filed: March 25, 1999
    Date of Patent: January 7, 2003
    Assignees: Schering-Plough Corporation, Genome Therapeutics Corporation
    Inventors: Roberta S. Hare, George H. Miller, Karen J. Shaw, George H. Shimer, Jr.
  • Lipophilic oligosaccharide antibiotic compositions
    Patent number: 5776912
    Abstract: An aqueous pharmaceutical composition comprising a lipophilic oligosaccharide antibiotic salt, e.g., the N-methylglucamine salt of the everninomicin-type antibiotic of Formula III together with a binding agent such as human serum albumin or recombinant human albumin and a tonicity agent such as mannitol, is disclosed.
    Type: Grant
    Filed: December 20, 1996
    Date of Patent: July 7, 1998
    Assignee: Schering Corporation
    Inventors: Mahesh G. Patel, Vincent P. Gullo, Roberta S. Hare, David Loebenberg, Heewon Y. Kwon, George H. Miller